Krsnaa Diagnostics Q2FY26 Concall Decoded: “From Rural Scans to Retail Dreams — India’s Diagnostic Mission Gets a Reality Check”
1. Opening Hook
While most diagnostics players chase wellness packages and influencer tie-ups, Krsnaa’s still busy installing MRI machines in small-town Rajasthan. In a world obsessed with fitness bands, they’re building something heavier — literally and financially. The management called it “a mission,” not a business. That’s cute — until you realize it’s working. With PPP tenders, retail dreams, and 18% EBITDA growth, Krsnaa’s trying to pull off the rarest of healthcare miracles: make diagnostics affordable and profitable. Stick around — it gets radiologically interesting from here.
2. At a Glance
Revenue ₹206 crore (↑11% YoY) – Growth without tender wins; that’s either genius or divine intervention.
EBITDA ₹60 crore (↑18%) – Margins up to 29%; spreadsheets finally smiling.
PAT ₹24 crore (↑22%) – Profits found a pulse again.
ROCE → 15% – Capital efficiency’s no longer on life support.
Receivables: 150 days – Government payments still taking their sweet bureaucratic time.
Retail biz up 60% QoQ – Apparently, people do want blood tests with brand recall.
3. Management’s Key Commentary
“We deliver services 40–60% cheaper than market rates.” (Translation: our margins are slim, but the goodwill’s fat. 😏)
“Krsnaa now operates the largest fleet of 200+ CT & MRI centers in India.” (Translation: more machines than competitors, fewer naps for technicians.)
“Despite PPP contract expirations, revenue grew 11% YoY.” (Translation: we patched old contracts faster than new ones could expire.)
“Retail business grew 60% QoQ; target 15–20% of revenue next year.” (Translation: from government corridors to shopping malls — evolution complete.)
“Receivables at 150 days but will normalize to 100.” (Translation: we’ll believe it when the RBI link account starts linking.)
“Our Rajasthan PPP project is progressing on schedule.” (Translation: no delays yet. That’s newsworthy for a government project.)
“Retail breakeven expected at ₹100 crore revenue mark.” (Translation: till then, it’s bleeding cash to collect blood.)
